STOCK TITAN

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
crypto

Enlivex (Nasdaq: ENLV) announced that its treasury token RAIN began trading on the KuCoin exchange effective January 6, 2026. The listing places RAIN on a major global venue that serves more than 40 million users and ranks among the top ten cryptocurrency exchanges.

Company commentary says the KuCoin listing is expected to expand global market access and secondary liquidity for Enlivex's primary digital treasury holding. KuCoin offers spot trading, derivatives, and yield services and has a strong user base in Southeast Asia. RAIN is described as the governance and utility token of a decentralized predictions and options protocol on Arbitrum.

Loading...
Loading translation...

Positive

  • RAIN listed on KuCoin effective January 6, 2026
  • Access to KuCoin's 40 million+ users
  • Spot, derivatives, and yield products available for RAIN

Negative

  • No quantified trading volume or liquidity metrics disclosed
  • No financial impact or proceeds from listing provided

News Market Reaction – ENLV

+0.37%
1 alert
+0.37% News Effect
+$719K Valuation Impact
$195M Market Cap
0.5x Rel. Volume

On the day this news was published, ENLV gained 0.37%, reflecting a mild positive market reaction. This price movement added approximately $719K to the company's valuation, bringing the market cap to $195M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Price change 24h: 4.82% KuCoin users: more than 40 million RAIN KuCoin listing date: January 6, 2026
3 metrics
Price change 24h 4.82% Move prior to RAIN KuCoin listing news
KuCoin users more than 40 million Global user base of KuCoin exchange
RAIN KuCoin listing date January 6, 2026 Effective date RAIN token began trading on KuCoin

Market Reality Check

Price: $1.01 Vol: Volume 257,525 is below t...
low vol
$1.01 Last Close
Volume Volume 257,525 is below the 20-day average of 682,873, indicating muted trading interest pre-announcement. low
Technical Price at 0.8191 is trading below the 200-day MA of 1.06, reflecting a longer-term downtrend.

Peers on Argus

ENLV gained 4.82% while peers showed mixed moves: TENX up 6.16%, ICU up 1.18%, Q...

ENLV gained 4.82% while peers showed mixed moves: TENX up 6.16%, ICU up 1.18%, QTTB up 0.6%, AKTX up 0.31%, and RNTX down 2.4%, suggesting a company-specific response to the RAIN listing news rather than a broad biotech move.

Historical Context

5 past events · Latest: Dec 04 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 04 Corporate update Positive +5.5% Announced fireside chat on RAIN treasury strategy and Allocetra development.
Nov 26 Financing close Negative -8.2% Closed large private placement to fund RAIN-focused digital asset treasury.
Nov 24 Management & financing Positive +13.7% Announced $212M private placement at premium and Matteo Renzi board appointment.
Nov 24 PIPE financing Positive +13.7% Detailed $212M PIPE to fund RAIN token treasury and ongoing clinical work.
Nov 24 Clinical data update Positive +13.7% Reported positive Phase IIa knee osteoarthritis pain and function data.
Pattern Detected

News tied to RAIN strategy and positive clinical data has often coincided with strong positive price reactions, while the financing close saw a negative move.

Recent Company History

Over the past few months, Enlivex has combined major financing with a pivot toward a digital asset treasury strategy centered on the RAIN token. Multiple announcements in late November 2025 detailed a $212,000,000 private placement and PIPE at $1.00 per share and highlighted RAIN-focused treasury plans and board changes. Positive Phase IIa knee osteoarthritis data with pain and function improvement supported the core biotech story. Today’s KuCoin listing continues the build-out of that RAIN-centric treasury approach.

Market Pulse Summary

This announcement extends Enlivex’s digital asset treasury strategy by listing its primary RAIN toke...
Analysis

This announcement extends Enlivex’s digital asset treasury strategy by listing its primary RAIN token holding on KuCoin, a large exchange serving over 40 million users. It follows recent financing and prior disclosures focused on accumulating RAIN and building a crypto-based treasury alongside ongoing clinical work. Investors may track subsequent exchange listings, treasury allocation updates, and clinical milestones to understand how the RAIN strategy and biotech pipeline evolve together.

Key Terms

cryptocurrency exchange, governance and utility token, decentralized predictions and options protocol, Arbitrum network, +1 more
5 terms
cryptocurrency exchange financial
"RAIN token, has been listed on the KuCoin cryptocurrency exchange effective"
A cryptocurrency exchange is an online marketplace where people buy, sell and swap digital currencies, similar to a stock exchange or a foreign currency desk at a bank. It matters to investors because exchanges set prices, provide liquidity (how easily an asset can be traded), hold or facilitate custody of tokens, and can affect trading costs and risk through fees, outages, or regulatory actions—factors that directly influence investment returns and safety.
governance and utility token financial
"RAIN serves as the governance and utility token of a fully decentralized"
A governance and utility token is a digital token that both powers use of a platform’s services (utility) and gives holders a voice in decisions about the platform (governance). Think of it as a combined membership card and voting ballot: it can be spent or staked to access features, and it can be used to influence product changes, fees, or rules. Investors care because the token’s value depends on how widely the platform is used and how much control holders can exercise, so demand, governance outcomes and regulatory risk can all affect price.
decentralized predictions and options protocol technical
"token of a fully decentralized predictions and options protocol built on"
A decentralized predictions and options protocol is a software system on a distributed ledger that lets people place bets on future events and create option-like contracts without a central company controlling it. Think of it as a peer-to-peer market where users can buy, sell or insure outcomes—similar to a prediction market combined with options trading—which matters to investors because it can enable new ways to hedge risk, discover market sentiment, and access tradable claims without traditional intermediaries.
Arbitrum network technical
"options protocol built on the Arbitrum network. The protocol enables users"
Arbitrum Network is a blockchain system that sits on top of Ethereum and handles many transactions off the main chain, then records a single summary back to Ethereum to save time and fees. Think of it like a shuttle bus that carries many passengers together so each person pays less than driving separately. Investors watch it because faster, cheaper transactions can boost usage of decentralized apps, affect token values, and change the economics and risk profile of crypto-related investments.
on-chain technical
"events through a transparent and automated on-chain framework."
On-chain describes actions or data that are recorded directly on a blockchain, a public digital ledger that creates a permanent, time-stamped record of transactions. For investors, on-chain activity provides verifiable evidence of transfers, ownership changes or automated program actions (like contract-driven payments); seeing these entries is like checking a bank statement and helps assess liquidity, settlement finality, fees, and transparency when judging risk and market behavior.

AI-generated analysis. Not financial advice.

The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex’s primary digital treasury asset

Nes-Ziona, Israel, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”) today reported that its treasury asset, the RAIN token, has been listed on the KuCoin cryptocurrency exchange effective January 6, 2026, expanding access to the token across a major global digital asset trading platform.

KuCoin is a global cryptocurrency exchange serving more than 40 million users worldwide, with its strongest user base in Southeast Asia. Founded in 2017, KuCoin consistently ranks among the top ten cryptocurrency exchanges globally and operates as an established digital asset trading venue, offering deep retail liquidity, and a full suite of products including spot trading, derivatives, and yield services. The commencement of RAIN trading on KuCoin is expected to expand global market access and secondary liquidity for Enlivex’s primary digital asset treasury holding.

“RAIN is the primary asset of Enlivex’s digital asset treasury, and we view developments such as exchange listings as meaningful milestones that may support liquidity and market access for our treasury holdings,” said Shai Novik, Chairman of the Board of Directors of Enlivex. “Over time, we expect continued progress in market access to further support the positioning of our treasury strategy.”

Enlivex previously announced the launch of its digital asset treasury strategy focused on the acquisition of RAIN tokens. RAIN serves as the governance and utility token of a fully decentralized predictions and options protocol built on the Arbitrum network. The protocol enables users globally to create, trade, and resolve markets tied to real-world events through a transparent and automated on-chain framework.

ABOUT ENLIVEX

Enlivex is first publicly-listed company to have developed a treasury strategy centered on RAIN, which currently serves as the primary treasury reserve asset of the Company. In adopting its new treasury policy, Enlivex intends to provide investors with exposure to RAIN and to advocate for its role as digital capital.

In addition, Enlivex has an operating business focused on late-stage clinical development of Allocetra™, a novel therapy designed to treat the joint disease osteoarthritis. Osteoarthritis is by far the most common form of arthritis, affecting more than 32.5 million Americans and more than 300 million individuals worldwide. About half of knees with ACL injuries develop osteoarthritis within 5 to 15 years. 78 million Americans are projected to have osteoarthritis by the year 2040. Symptomatic knee osteoarthritis is particularly prevalent and disabling, with 40% of men and 47% of women developing knee osteoarthritis in their lifetimes. Osteoarthritis accounts for over one million hospitalizations annually in the United States, primarily for total joint replacement. The burden of osteoarthritis is enormous, and the need for treatments that reduce pain and attendant disability for persons with osteoarthritis is critical. To the Company’s knowledge, there are currently no medications approved by either the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) that have been demonstrated to arrest, slow or reverse progression of structural damage in the joint.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would,” “could,” “intends,” “estimates,” “suggests,” “target,” “has the potential to,” “goal,” and other words of similar meaning, including statements relating to the anticipated benefits of the Company’s digital asset treasury strategy; the assets to be held by the Company; the expected future market, price, trading activity, and liquidity of the RAIN token; the impact of expanded exchange listings and increased token liquidity on market participation and accessibility; the potential effects of digital asset liquidity on the liquidity of the Company’s ordinary shares; macroeconomic, political, and regulatory conditions surrounding digital assets; the Company’s plans for value creation and strategic positioning; market size and growth opportunities; regulatory conditions; competitive position; technological and market trends; future financial condition and performance; expected clinical trial results; market opportunities for the results of current clinical studies and preclinical experiments; and the effectiveness of, and market opportunities for, ALLOCETRA™ programs.

Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the risk of failure to realize the anticipated benefits of the Company’s digital asset treasury strategy; changes in business, market, financial, political, and regulatory conditions; risks relating to the Company’s operations and business, including the highly volatile nature of the price, trading volume, and liquidity of RAIN and other cryptocurrencies; risks associated with digital asset exchange listings, trading venues, and market infrastructure; the risk that the price and liquidity of the Company’s ordinary shares may be correlated with the price or liquidity of the digital assets it holds; risks related to increased competition in the industries in which the Company operates; risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; and those risks and uncertainties identified in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except as required by applicable law.no obligation to update or revise any of these statements, except as required by applicable law.

ENLIVEX CONTACT

Shachar Shlosberger, CFO
Enlivex Therapeutics, Ltd.
shachar@enlivex.com

INVESTOR RELATIONS CONTACT

KCSA Strategic Communications
Jack Perkins
Enlivex@KCSA.com


FAQ

When did Enlivex (ENLV) list the RAIN token on KuCoin?

RAIN began trading on KuCoin effective January 6, 2026.

What does the KuCoin listing mean for Enlivex (ENLV) treasury liquidity?

The company expects the listing to expand market access and secondary liquidity for its RAIN treasury holding.

How large is KuCoin's user base for RAIN trading tied to Enlivex (ENLV)?

KuCoin serves more than 40 million users, with a strong base in Southeast Asia.

Can investors trade RAIN using derivatives or yield products on KuCoin after the ENLV announcement?

KuCoin offers spot trading, derivatives, and yield services, which are available for listed tokens including RAIN.

What is the role of the RAIN token in Enlivex's (ENLV) treasury strategy?

RAIN is the primary asset of Enlivex's digital asset treasury and serves as a governance and utility token for a protocol on Arbitrum.

Does Enlivex (ENLV) disclose expected revenue or proceeds from the RAIN KuCoin listing?

No; the announcement does not disclose any financial proceeds or quantified trading volumes from the listing.
Enlivex Therapeutics Ltd

NASDAQ:ENLV

ENLV Rankings

ENLV Latest News

ENLV Latest SEC Filings

ENLV Stock Data

249.25M
236.28M
Biotechnology
Healthcare
Link
Israel
Ness Ziona